Erasca Inc (NAS:ERAS)
$ 15.94 +1.06 (+7.09%) Market Cap: 4.96 Bil Enterprise Value: 4.76 Bil PE Ratio: 0 PB Ratio: 12.59 GF Score: 22/100

Erasca Inc at Bank of America Global Healthcare Conference Transcript

May 13, 2026 / 10:00 PM GMT
Release Date Price: $10.46 (+0.77%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ERAS.OQ - Erasca Inc
Erasca Inc at Bank of America Global Healthcare Conference
May 13, 2026 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hey, everyone. Thanks for joining this session with Araska. My name is Alex Stranahan. I cover Smith Biotech at Bank of America, and I'm covering analysts for Araska. And I have the pleasure of introducing and being joined by Jonathan Lim, Chairman and CEO, and David Ciocco, Chief Financial Officer and CBO of Araska. Thanks for being here, guys.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Alec. Great to be here.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot